Spinal internal fixation system, interlaminal

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Emergo Asia Pacific Pty Ltd T/a Emergo Australia

Classe:

Class IIb

Prodotto da:

Signus Medizintechnik GmbH Industriestrasse 2, Alzenau, D-63755 Germany

Area terapeutica:

43041 - Spinal internal fixation system, interlaminal

Indicazioni terapeutiche:

The system is indicated for the stabilisation of the thoracic/lumbar spine (T2 - L5) in patients until stable fusion of the spine has been achieved after surgery. The system is indicated for: Spinal instability or malpositioning, Fractures, Postoperative or degenerative instability, Tumours and spondylodiscitis, Correction of Meyerding grade 1 spondylolisthesis, Disc prolapse, Stenosis of the lumbar spine, Disc resection, Abnormal lordosis/kyphosis/scoliosis, and Segment degeneration.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2013-10-31